COSETTE Pharmaceuticals has announced the authorization of a new NDA, marking its latest portfolio expansion following the 2026 product launch. Financial analysts anticipate this strategic addition will drive revenue growth and further solidify the company's position in the expanding pharmaceutical marketplace.